692 related articles for article (PubMed ID: 12667224)
1. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.
Le Bras J; Durand R
Fundam Clin Pharmacol; 2003 Apr; 17(2):147-53. PubMed ID: 12667224
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms and dynamics of drug resistance in Plasmodium falciparum].
Le Bras J
Bull Soc Pathol Exot; 1999; 92(4):236-41. PubMed ID: 10572658
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms and epidemiology of resistances to antimalarials].
Le Bras J; Basco LK; de Pécoulas PE
C R Seances Soc Biol Fil; 1996; 190(4):471-85. PubMed ID: 8952898
[TBL] [Abstract][Full Text] [Related]
4. [Molecular aspects of chloroquine and antifols resistance in P. falciparum].
Le Bras J; Durand R
Ann Pharm Fr; 2001 Apr; 59(2):85-92. PubMed ID: 11320332
[TBL] [Abstract][Full Text] [Related]
5. [Antimalarial drug resistance].
Le Bras J; Musset L; Clain J
Med Mal Infect; 2006 Aug; 36(8):401-5. PubMed ID: 16854546
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
7. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
Henry M; Diallo I; Bordes J; Ka S; Pradines B; Diatta B; M'Baye PS; Sane M; Thiam M; Gueye PM; Wade B; Touze JE; Debonne JM; Rogier C; Fusai T
Am J Trop Med Hyg; 2006 Jul; 75(1):146-51. PubMed ID: 16837722
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
Djaman AJ; Basco LK; Mazabraud A
Sante; 2002; 12(4):363-7. PubMed ID: 12626289
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of drug-resistant malaria.
Wongsrichanalai C; Pickard AL; Wernsdorfer WH; Meshnick SR
Lancet Infect Dis; 2002 Apr; 2(4):209-18. PubMed ID: 11937421
[TBL] [Abstract][Full Text] [Related]
11. Identification of pyrimethamine- and chloroquine-resistant Plasmodium falciparum in Africa between 1984 and 1998: genotyping of archive blood samples.
Saito-Nakano Y; Tanabe K; Mita T
Malar J; 2011 Dec; 10():388. PubMed ID: 22208458
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
Basco LK; Ramiliarisoa O; Le Bras J
Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
[TBL] [Abstract][Full Text] [Related]
13. A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
Carnevale EP; Kouri D; DaRe JT; McNamara DT; Mueller I; Zimmerman PA
J Clin Microbiol; 2007 Mar; 45(3):752-61. PubMed ID: 17121999
[TBL] [Abstract][Full Text] [Related]
14. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR.
Berens N; Schwoebel B; Jordan S; Vanisaveth V; Phetsouvanh R; Christophel EM; Phompida S; Jelinek T
Trop Med Int Health; 2003 Sep; 8(9):775-82. PubMed ID: 12950663
[TBL] [Abstract][Full Text] [Related]
16. Genetic and biochemical aspects of drug resistance in malaria parasites.
Hayton K; Su XZ
Curr Drug Targets Infect Disord; 2004 Mar; 4(1):1-10. PubMed ID: 15032630
[TBL] [Abstract][Full Text] [Related]
17. Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau.
Kofoed PE; Alfrangis M; Poulsen A; Rodrigues A; Gjedde SB; Rønn A; Rombo L
Trop Med Int Health; 2004 Jan; 9(1):171-7. PubMed ID: 14728622
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests.
Rason MA; Ariey F; Rafidimanantsoa L; Andrianantenaina BH; Sahondra Harisoa JL; Randrianarivelojosia M
Parasite; 2002 Sep; 9(3):247-53. PubMed ID: 12375368
[TBL] [Abstract][Full Text] [Related]
19. Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India.
Mixson-Hayden T; Jain V; McCollum AM; Poe A; Nagpal AC; Dash AP; Stiles JK; Udhayakumar V; Singh N
Antimicrob Agents Chemother; 2010 Mar; 54(3):997-1006. PubMed ID: 20038626
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of malaria in Cameroon. XII. In vitro drug assays and molecular surveillance of chloroquine and proguanil resistance.
Basco LK
Am J Trop Med Hyg; 2002 Oct; 67(4):383-7. PubMed ID: 12455495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
